Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
The fastest-growing areas for LATAM’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Americas | IVD Gateway | Next Generation Sequencing (NGS)
The fastest-growing areas for APAC’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Next Generation Sequencing (NGS)
2022 healthcare megatrends shaping IVD 2022 healthcare megatrends shaping IVD… In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT) | Asia | Europe | Middle East & Africa | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
Rapid antigen tests to erode PCR-based molecular covid test market in APAC Emergent covid-19 screening technologies coupled with… Covid-19 testing | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Molecular diagnostics instrument sales in Asia-Pacific set to normalise as vaccination rates rise Molecular diagnostics (MDX) instrument sales in Asia-Pacific… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: Molecular testing capacity expands in Asia-Pacific Molecular diagnostics (MDx) testing capacities and… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: accelerating digitalisation of surgical platforms and solutions The covid-19 pandemic has accelerated the rise of telehealth… Covid-19 testing | General surgery | Global | Surgical Gateway
Tissue-based companion diagnostics market to grow for the most common cancers in China Companion diagnostics (CDx) use is growing as the cancer… In-vitro diagnostics | Tissue Diagnostics (TDx) | Asia | IVD Gateway | Tissue Diagnostics (TDx)
Competition in the APAC IVD infectious diseases diagnostics market Competition in Asia-Pacific’s infectious diseases… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | IVD Gateway
Point-of-care vs. lab-based covid-19 testing Covid-19 testing has emerged as a top priority for clinical… In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Infectious disease IVD testing: Where APAC countries are putting their attention Economist Intelligence Clearstate expects strong growth for… In-vitro diagnostics | Asia | IVD Gateway
Digital pathology growth to outpace broader TDx market in several countries Laboratories that adopt digital pathology, support the… In-vitro diagnostics | Tissue Diagnostics (TDx) | IVD Gateway | Tissue Diagnostics (TDx)
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now